Roundview Capital LLC Sells 62 Shares of Mettler-Toledo International, Inc. $MTD

Roundview Capital LLC decreased its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 4.8% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,239 shares of the medical instruments supplier’s stock after selling 62 shares during the period. Roundview Capital LLC’s holdings in Mettler-Toledo International were worth $1,455,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of MTD. Farther Finance Advisors LLC grew its position in shares of Mettler-Toledo International by 39.1% in the first quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier’s stock valued at $103,000 after purchasing an additional 25 shares during the last quarter. QRG Capital Management Inc. grew its position in shares of Mettler-Toledo International by 29.4% in the first quarter. QRG Capital Management Inc. now owns 489 shares of the medical instruments supplier’s stock valued at $577,000 after purchasing an additional 111 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in shares of Mettler-Toledo International by 13.3% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,488 shares of the medical instruments supplier’s stock valued at $2,929,000 after purchasing an additional 292 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its position in shares of Mettler-Toledo International by 95.0% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier’s stock valued at $2,600,000 after purchasing an additional 1,073 shares during the last quarter. Finally, Boston Trust Walden Corp grew its position in shares of Mettler-Toledo International by 7.1% in the first quarter. Boston Trust Walden Corp now owns 34,610 shares of the medical instruments supplier’s stock valued at $40,871,000 after purchasing an additional 2,296 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently commented on MTD. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Mettler-Toledo International in a research report on Saturday, September 27th. Robert W. Baird upped their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research report on Monday, August 4th. Citigroup increased their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Thursday, August 21st. Barclays increased their price target on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the stock an “overweight” rating in a research report on Thursday, October 2nd. Finally, Bank of America increased their price target on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research report on Monday, September 22nd. Five investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $1,342.22.

Mettler-Toledo International Price Performance

NYSE MTD opened at $1,305.67 on Wednesday. The business has a fifty day moving average price of $1,274.75 and a two-hundred day moving average price of $1,187.87. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,486.76. The stock has a market capitalization of $26.90 billion, a PE ratio of 33.06, a PEG ratio of 4.04 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company had revenue of $983.22 million during the quarter, compared to analysts’ expectations of $957.41 million. During the same period in the prior year, the company earned $9.65 EPS. Mettler-Toledo International’s revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, sell-side analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Insider Activity

In other news, CFO Shawn Vadala sold 300 shares of the stock in a transaction on Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total value of $376,227.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares in the company, valued at approximately $6,389,588.55. This represents a 5.56% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the completion of the transaction, the director owned 283 shares of the company’s stock, valued at $368,154.70. The trade was a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,827 shares of company stock worth $2,371,208. Insiders own 0.77% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.